Cargando…

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858826/ https://www.ncbi.nlm.nih.gov/pubmed/29589598 http://dx.doi.org/10.2147/BCTT.S166117

Ejemplares similares

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
por: Criscitiello, Carmen, et al.
Publicado: (2018)

Evaluating the Therapeutic Potential of Zanubrutinib in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma: Evidence to Date [Corrigendum]
Publicado: (2020)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
Publicado: (2014)

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus [Corrigendum]
Publicado: (2015)

Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum]
Publicado: (2015)

Corrigendum to: Differences in gene-expression profiles in breast cancer between African and European-ancestry women
por: Ping, Jie, et al.
Publicado: (2020)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Publicado: (2014)

Corrigendum to “Treatment of Breast and Prostate Cancer by Hypofractionated Radiotherapy: Potential Risks and Benefits” [Clin Oncol 27 (7) (2015) 420–426]
por: Ray, K.J., et al.
Publicado: (2016)

Subcellular Organelle-Targeted Nanostructured Lipid Carriers for the Treatment of Metastatic Breast Cancer [Corrigendum]
Publicado: (2023)

Risk Assessment for Breast Cancer Development and Its Clinical Impact on Screening Performance in Iranian Women [Corrigendum]
Publicado: (2021)

Corrigendum to: Modification of ERα by UFM1 Increases Its Stability and Transactivity for Breast Cancer Development
por: Yoo, Hee Min, et al.
Publicado: (2023)

Taxanes in the elderly patient with metastatic breast cancer [Corrigendum]
Publicado: (2019)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Publicado: (2019)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Publicado: (2014)

Corrigendum to “Recent Advances in Microwave Imaging for Breast Cancer Detection”
por: Kwon, Sollip, et al.
Publicado: (2018)

Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]
Publicado: (2020)

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]
Publicado: (2014)

Corrigendum: ICTV Virus Taxonomy Profile: Ophioviridae
por: García, María Laura, et al.
Publicado: (2018)

Corrigendum: ICTV Virus Taxonomy Profile: Chrysoviridae
por: Ghabrial, Said A., et al.
Publicado: (2018)

The role of taxanes in triple-negative breast cancer: literature review [Corrigendum]
Publicado: (2015)

Corrigendum to “Expression of HE4 in Endometrial Cancer and Its Clinical Significance”
por: Li, Xiao, et al.
Publicado: (2018)

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]
Publicado: (2021)

Corrigendum to “The Role of Antioxidants in Skin Cancer Prevention and Treatment”
por: Godić, Aleksandar, et al.
Publicado: (2020)

Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection [Corrigendum]
Publicado: (2021)

Corrigendum to “Cytotoxic Effect of Ethanol Extract of Microalga, Chaetoceros calcitrans, and Its Mechanisms in Inducing Apoptosis in Human Breast Cancer Cell Line”
por: Ebrahimi Nigjeh, Siyamak, et al.
Publicado: (2016)

Profile of eliglustat tartrate in the management of Gaucher disease [Corrigendum]
Publicado: (2016)

The role of IRAK1 in breast cancer patients treated with neoadjuvant chemotherapy [Corrigendum]
Publicado: (2019)

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures [Corrigendum]
Publicado: (2015)

Profile of pridopidine and its potential in the treatment of Huntington disease: the evidence to date
por: Squitieri, Ferdinando, et al.
Publicado: (2015)

Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
por: Pievsky, Daniel, et al.
Publicado: (2016)

Corrigendum to: Optimisation of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9 to 12 months after treatment
por: Nordell, Fabian, et al.
Publicado: (2022)

Corrigendum to “Breast Cancer Survival and Incidence: 10 Years Cancer Registry Data in the Northwest, Iran”
por: Dolatkhah, Roya, et al.
Publicado: (2021)

Corrigendum to “Potential Extensions of the US FRAX Algorithm”
por: Osteoporosis, Journal of
Publicado: (2018)

Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014)

Causal inference with observational data: the need for triangulation of evidence – CORRIGENDUM
por: Hammerton, Gemma, et al.
Publicado: (2021)

Corrigendum to: Are there ‘two sides’ to attacks on healthcare? Evidence from Palestine
Publicado: (2021)

Corrigendum to “Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer”
por: Yang, Guangda, et al.
Publicado: (2020)

Corrigendum: Comparisons of Gastric Cancer Treatments: East vs. West
por: Bickenbach, Kai, et al.
Publicado: (2012)

Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum]
Publicado: (2022)

Pulmonary hemodynamic profile in chronic obstructive pulmonary disease [Corrigendum]
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7c0unnlq9ja04tibod0oi729n6